| NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy N Guerra, YX Tan, NT Joncker, A Choy, F Gallardo, N Xiong, S Knoblaugh, ... Immunity 28 (4), 571-580, 2008 | 995 | 2008 |
| Oncogenic stress sensed by the immune system: role of natural killer cell receptors DH Raulet, N Guerra Nature Reviews Immunology 9 (8), 568-580, 2009 | 465 | 2009 |
| Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma EC Ibrahim, N Guerra, MJT Lacombe, E Angevin, S Chouaib, ... Cancer research 61 (18), 6838-6845, 2001 | 219 | 2001 |
| Immune-based therapies for hepatocellular carcinoma DJ Pinato, N Guerra, P Fessas, R Murphy, T Mineo, FA Mauri, ... Oncogene 39 (18), 3620-3637, 2020 | 184 | 2020 |
| Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade E Bonavita, CP Bromley, G Jonsson, VS Pelly, S Sahoo, K Walwyn-Brown, ... Immunity 53 (6), 1215-1229. e8, 2020 | 157 | 2020 |
| Costimulation of dendritic epidermal γδ T cells by a new NKG2D ligand expressed specifically in the skin MI Whang, N Guerra, DH Raulet The Journal of Immunology 182 (8), 4557-4564, 2009 | 117 | 2009 |
| Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis M Xia, N Guerra, GK Sukhova, K Yang, CK Miller, GP Shi, DH Raulet, ... Circulation 124 (25), 2933-2943, 2011 | 98 | 2011 |
| Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas N Guerra, M Guillard, E Angevin, H Echchakir, B Escudier, A Moretta, ... Blood, The Journal of the American Society of Hematology 95 (9), 2883-2889, 2000 | 93 | 2000 |
| CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling A Gati, N Guerra, C Gaudin, S Da Rocha, B Escudier, Y Lécluse, ... Cancer research 63 (21), 7475-7482, 2003 | 62 | 2003 |
| The paradoxical role of NKG2D in cancer immunity S Sheppard, A Ferry, J Guedes, N Guerra Frontiers in immunology 9, 380207, 2018 | 61 | 2018 |
| Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation⋆ N Farhadi, L Lambert, C Triulzi, PJM Openshaw, N Guerra, FJ Culley Journal of Allergy and Clinical Immunology 133 (3), 827-835. e3, 2014 | 60 | 2014 |
| Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction N Guerra, F Michel, A Gati, C Gaudin, Z Mishal, B Escudier, O Acuto, ... Blood, The Journal of the American Society of Hematology 100 (8), 2874-2881, 2002 | 60 | 2002 |
| Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer P Collery, A Mohsen, A Kermagoret, S Corre, G Bastian, A Tomas, M Wei, ... Investigational new drugs 33, 848-860, 2015 | 56 | 2015 |
| A selective role of NKG2D in inflammatory and autoimmune diseases N Guerra, K Pestal, T Juarez, J Beck, K Tkach, L Wang, DH Raulet Clinical Immunology 149 (3), 432-439, 2013 | 56 | 2013 |
| The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma S Sheppard, J Guedes, A Mroz, AM Zavitsanou, H Kudo, SM Rothery, ... Nature Communications 8 (1), 13930, 2017 | 53 | 2017 |
| Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor function A Gati, N Guerra, J Giron-Michel, B Azzarone, E Angevin, A Moretta, ... Cancer research 61 (8), 3240-3244, 2001 | 52 | 2001 |
| Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death S Chouaib, J Thiery, A Gati, N Guerra, M El Behi, G Dorothee, ... Tissue Antigens 60 (4), 273-281, 2002 | 51 | 2002 |
| The murine natural cytotoxic receptor NKp46/NCR1 controls TRAIL protein expression in NK cells and ILC1s S Sheppard, IS Schuster, CE Andoniou, C Cocita, T Adejumo, SKP Kung, ... Cell reports 22 (13), 3385-3392, 2018 | 49 | 2018 |
| Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness M Cadoux, S Caruso, S Pham, A Gougelet, C Pophillat, R Riou, R Loesch, ... Journal of Hepatology 74 (6), 1386-1397, 2021 | 46 | 2021 |
| Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients A Gati, S Da Rocha, N Guerra, B Escudier, A Moretta, S Chouaib, ... International journal of cancer 109 (3), 393-401, 2004 | 45 | 2004 |
